Bispecific antibody platforms for cancer immunotherapy

被引:65
作者
Lameris, Roeland [1 ]
de Bruin, Renee C. G. [1 ]
Schneiders, Famke L. [1 ]
Henegouwen, Paul M. P. van Bergen en [2 ]
Verheul, Henk M. W. [1 ]
de Gruijl, Tanja D. [1 ]
van der Vliet, Hans J. [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands
[2] Univ Utrecht, Fac Sci, Dept Biol, Div Cell Biol, NL-3584 CH Utrecht, Netherlands
关键词
Bi-specific antibodies; Dual specific retargeting; Immune effector cells; Anti-cancer therapy; NATURAL-KILLER-CELLS; DELTA T-CELLS; SINGLE-CHAIN ANTIBODY; EPCAM X ANTI-CD3; ACUTE LYMPHOBLASTIC-LEUKEMIA; EXPRESSING TUMOR-CELLS; NKT CELLS; MALIGNANT ASCITES; ANTITUMOR-ACTIVITY; PROSTATE-CANCER;
D O I
10.1016/j.critrevonc.2014.08.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over the past decades advances in bioengineering and expanded insight in tumor immunology have resulted in the emergence of novel bispecific antibody (bsAb) constructs that are capable of redirecting immune effector cells to the tumor microenvironment. (Pre-) clinical studies of various bsAb constructs have shown impressive results in terms of immune effector cell retargeting, target dependent activation and the induction of anti-tumor responses. This review summarizes recent advances in the field of bsAb-therapy and limitations that were encountered. Furthermore, we will discuss potential future developments that can be expected to take the bsAb approach successfully forward. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:153 / 165
页数:13
相关论文
共 120 条
[1]  
Ali Tahir SM, 2001, J IMMUNOL, V167, P4046
[2]   Diabody-based recombinant formats of humanized IgG-like bispecific antibody with effective retargeting, of lymphocytes to tumor cells [J].
Asano, Ryutaro ;
Kawaguchi, Hiroko ;
Watanabe, Yasuhiro ;
Nakanishi, Takeshi ;
Umetsu, Mitsuo ;
Hayashi, Hiroki ;
Katayose, Yu ;
Unno, Michiaki ;
Kudo, Toshio ;
Kumagai, Izumi .
JOURNAL OF IMMUNOTHERAPY, 2008, 31 (08) :752-761
[3]   Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent [J].
Asano, Ryutaro ;
Sone, Yukiko ;
Makabe, Koki ;
Tsumoto, Kouhei ;
Hayashi, Hiroki ;
Katayose, Yu ;
Unno, Michiaki ;
Kudo, Toshio ;
Kumagai, Izumi .
CLINICAL CANCER RESEARCH, 2006, 12 (13) :4036-4042
[4]   Domain order of a bispecific diabody dramatically enhances its antitumor activity beyond structural format conversion: the case of the hEx3 diabody [J].
Asano, Ryutaro ;
Kumagai, Takashi ;
Nagai, Keisuke ;
Taki, Shintaro ;
Shimomura, Ippei ;
Arai, Kyoko ;
Ogata, Hiromi ;
Okada, Mai ;
Hayasaka, Fumitaka ;
Sanada, Hideaki ;
Nakanishi, Takeshi ;
Karvonen, Teemu ;
Hayashi, Hiroki ;
Katayose, Yu ;
Unno, Michiaki ;
Kudo, Toshio ;
Umetsu, Mitsuo ;
Kumagai, Izumi .
PROTEIN ENGINEERING DESIGN & SELECTION, 2013, 26 (05) :359-367
[5]   Cytotoxic Enhancement of a Bispecific Diabody by Format Conversion to Tandem Single-chain Variable Fragment (taFv) THE CASE OF THE hEx3 DIABODY [J].
Asano, Ryutaro ;
Ikoma, Keiko ;
Shimomura, Ippei ;
Taki, Shintaro ;
Nakanishi, Takeshi ;
Umetsu, Mitsuo ;
Kumagai, Izumi .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (03) :1812-1818
[6]   Allogeneic natural killer cells for refractory lymphoma [J].
Bachanova, Veronika ;
Burns, Linda J. ;
McKenna, David H. ;
Curtsinger, Julie ;
Panoskaltsis-Mortari, Angela ;
Lindgren, Bruce R. ;
Cooley, Sarah ;
Weisdorf, Daniel ;
Miller, Jeffrey S. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (11) :1739-1744
[7]   Bispecific T-Cell Engaging Antibodies for Cancer Therapy [J].
Baeuerle, Patrick A. ;
Reinhardt, Carsten .
CANCER RESEARCH, 2009, 69 (12) :4941-4944
[8]   Tumor regression in cancer patients by very low doses of a T cell-engaging antibody [J].
Bargou, Ralf ;
Leo, Eugen ;
Zugmaier, Gerhard ;
Klinger, Matthias ;
Goebeler, Mariele ;
Knop, Stefan ;
Noppeney, Richard ;
Viardot, Andreas ;
Hess, Georg ;
Schuler, Martin ;
Einsele, Hermann ;
Brandl, Christian ;
Wolf, Andreas ;
Kirchinger, Petra ;
Klappers, Petra ;
Schmidt, Margit ;
Riethmueller, Gert ;
Reinhardt, Carsten ;
Baeuerle, Patrick A. ;
Kufer, Peter .
SCIENCE, 2008, 321 (5891) :974-977
[9]  
Baum V, 2013, IMMUNOTHERAPY-UK, V5, P27, DOI [10.2217/IMT.12.136, 10.2217/imt.12.136]
[10]   iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells [J].
Bellone, Matteo ;
Ceccon, Monica ;
Grioni, Matteo ;
Jachetti, Elena ;
Calcinotto, Arianna ;
Napolitano, Anna ;
Freschi, Massimo ;
Casorati, Giulia ;
Dellabona, Paolo .
PLOS ONE, 2010, 5 (01)